Phase 4 Cystic Fibrosis Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have been formally diagnosed with cystic fibrosis (CF) and whose specific CF gene type (genotype) is known
• People who are 2 years of age or older
• People (or their legal guardian) who are able to give written agreement to take part in the trial
• People who have been taking a triple combination CF modulator therapy (a type of CF medication involving three drugs together) at a stable, unchanged dose for at least two weeks before the first visit
• People whose lung disease has been stable — meaning no significant sudden drop in lung function (greater than 10%), and no need for extra antibiotic treatment (by mouth or through a drip) in the four weeks before screening

Who may not be able to join:

• People who have had a notable unintended loss of weight in the four weeks before screening, as assessed by the trial doctor
• People who are pregnant or currently breastfeeding
• People who have had a history of alcohol or substance misuse in the six months before screening
• People who have taken part in another clinical trial involving an experimental treatment within the 28 days (or longer, depending on the specific medication) before screening
• People who have a medical or mental health condition that, in the trial doctor's judgement, would make participation difficult or unsafe (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.